- Home
- PEPG vs ABLV Comparison
PEPG vs ABLV Comparison
Compare PEPG & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- ABLV
- Stock Information
- Founded
- PEPG 2018
- ABLV 2015
- Country
- PEPG United States
- ABLV China
- Employees
- PEPG N/A
- ABLV N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- ABLV
- Sector
- PEPG Health Care
- ABLV
- Exchange
- PEPG Nasdaq
- ABLV Nasdaq
- Market Cap
- PEPG 45.5M
- ABLV 50.9M
- IPO Year
- PEPG 2022
- ABLV N/A
- Fundamental
- Price
- PEPG $1.22
- ABLV $0.98
- Analyst Decision
- PEPG Buy
- ABLV
- Analyst Count
- PEPG 3
- ABLV 0
- Target Price
- PEPG $7.67
- ABLV N/A
- AVG Volume (30 Days)
- PEPG 290.3K
- ABLV 8.9K
- Earning Date
- PEPG 08-07-2025
- ABLV 04-23-2025
- Dividend Yield
- PEPG N/A
- ABLV N/A
- EPS Growth
- PEPG N/A
- ABLV N/A
- EPS
- PEPG N/A
- ABLV N/A
- Revenue
- PEPG N/A
- ABLV $128,932,647.00
- Revenue This Year
- PEPG N/A
- ABLV N/A
- Revenue Next Year
- PEPG N/A
- ABLV N/A
- P/E Ratio
- PEPG N/A
- ABLV N/A
- Revenue Growth
- PEPG N/A
- ABLV N/A
- 52 Week Low
- PEPG $0.88
- ABLV $0.55
- 52 Week High
- PEPG $19.30
- ABLV $1.90
- Technical
- Relative Strength Index (RSI)
- PEPG 41.13
- ABLV 39.80
- Support Level
- PEPG $1.05
- ABLV $1.02
- Resistance Level
- PEPG $1.49
- ABLV $1.13
- Average True Range (ATR)
- PEPG 0.10
- ABLV 0.08
- MACD
- PEPG -0.02
- ABLV -0.01
- Stochastic Oscillator
- PEPG 38.64
- ABLV 17.20
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.